131 related articles for article (PubMed ID: 35598794)
1. Synthesis and biological evaluation of new series of benzamide derivatives containing urea moiety as sEH inhibitors.
Tian Y; Li S; Yang P; Su X; Liu J; Lv X; Dong K; Yang T; Duan M; Hu G; Yue H; Sun Y; Sun Y; Zhang H; Du Z; Miao Z; Tong M; Hou Y; Gao Z; Zhao Y
Bioorg Med Chem Lett; 2022 Aug; 70():128805. PubMed ID: 35598794
[TBL] [Abstract][Full Text] [Related]
2. Discovery of benzamide derivatives containing urea moiety as soluble epoxide hydrolase inhibitors.
Tian Y; Li S; Dong K; Su X; Fu S; Lv X; Duan M; Yang T; Han Y; Hu G; Liu J; Sun Y; Yue H; Sun Y; Zhang H; Du Z; Miao Z; Tong M; Liu Y; Qin M; Gong P; Hou Y; Gao Z; Zhao Y
Bioorg Chem; 2022 Oct; 127():105898. PubMed ID: 35792317
[TBL] [Abstract][Full Text] [Related]
3. Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects.
Han Y; Huang D; Xu S; Li L; Tian Y; Li S; Chen C; Li Y; Sun Y; Hou Y; Sun Y; Qin M; Gong P; Gao Z; Zhao Y
Eur J Med Chem; 2021 Feb; 212():113028. PubMed ID: 33248848
[TBL] [Abstract][Full Text] [Related]
4. Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
Du F; Sun W; Morisseau C; Hammock BD; Bao X; Liu Q; Wang C; Zhang T; Yang H; Zhou J; Xiao W; Liu Z; Chen G
Eur J Med Chem; 2021 Nov; 223():113678. PubMed ID: 34218083
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
Çapan İ; Jordan PM; Olğaç A; Çalışkan B; Kretzer C; Werz O; Banoglu E
ChemMedChem; 2022 Jun; 17(12):e202200137. PubMed ID: 35466565
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase.
Hwang SH; Wagner KM; Morisseau C; Liu JY; Dong H; Wecksler AT; Hammock BD
J Med Chem; 2011 Apr; 54(8):3037-50. PubMed ID: 21434686
[TBL] [Abstract][Full Text] [Related]
7. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol.
Hejazi L; Ebadi A; Fakhar Z; Nazari M; Rezaee E; Abbas Tabatabai S
Chem Biodivers; 2022 Nov; 19(11):e202200231. PubMed ID: 36152343
[TBL] [Abstract][Full Text] [Related]
10. 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors:
Codony S; Pujol E; Pizarro J; Feixas F; Valverde E; Loza MI; Brea JM; Saez E; Oyarzabal J; Pineda-Lucena A; Pérez B; Pérez C; Rodríguez-Franco MI; Leiva R; Osuna S; Morisseau C; Hammock BD; Vázquez-Carrera M; Vázquez S
J Med Chem; 2020 Sep; 63(17):9237-9257. PubMed ID: 32787085
[No Abstract] [Full Text] [Related]
11. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
Hejazi L; Rezaee E; Tabatabai SA
Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
[TBL] [Abstract][Full Text] [Related]
12. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
[TBL] [Abstract][Full Text] [Related]
13. Identification of potent inhibitors of the chicken soluble epoxide hydrolase.
Shihadih DS; Harris TR; Yang J; Merzlikin O; Lee KS; Hammock BD; Morisseau C
Bioorg Med Chem Lett; 2015 Jan; 25(2):276-9. PubMed ID: 25479771
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.
Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD
Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531
[TBL] [Abstract][Full Text] [Related]
15. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
[TBL] [Abstract][Full Text] [Related]
16. Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.
Mahlooji I; Shokri M; Manoochehri R; Mahboubi-Rabbani M; Rezaee E; Tabatabai SA
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000052. PubMed ID: 32484272
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales.
Kitamura S; Morisseau C; Harris TR; Inceoglu B; Hammock BD
PLoS One; 2017; 12(5):e0176571. PubMed ID: 28472063
[TBL] [Abstract][Full Text] [Related]
18. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
[TBL] [Abstract][Full Text] [Related]
19. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
